Phase I/Pharmacokinetic Réévaluation of ThioTEPA1
暂无分享,去创建一个
P. Engstrom | S. Litwin | P. O'dwyer | F. LaCreta | D. Poplack | R. Comis | D. Cole | R. Peter | J. DeVito | R. Delap | L. Tartaglia | R. DeLap
[1] M. Egorin,et al. Cellular pharmacology of N,N',N''-triethylene thiophosphoramide. , 1988, Cancer letters.
[2] C. Begg,et al. Pharmacokinetics of continuous-infusion high-dose thiotepa. , 1987, Cancer treatment reports.
[3] T. Spitzer,et al. High-dose i.v. thiotepa and cryopreserved autologous bone marrow transplantation for therapy of refractory cancer. , 1987, Cancer treatment reports.
[4] M. Egorin,et al. Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion. , 1987, Cancer research.
[5] M. Egorin,et al. Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites. , 1986, Cancer treatment reports.
[6] D. Bigner,et al. Experimental chemotherapy of human medulloblastoma with classical alkylators. , 1986, Cancer research.
[7] D. Perrier,et al. Noncompartmental determination of the steady-state volume of distribution for any mode of administration. , 1982, Journal of pharmaceutical sciences.
[8] J. Holland,et al. One‐day vath (vinblastine, adriamycin, thiotepa, and halotestin) therapy for advanced breast cancer refractory to chemotherapy , 1981, Cancer.
[9] J. Holland,et al. Vinblastine, adriamycin, thiotepa, and halotestin (VATH). Therapy for advanced breast cancer refractory to prior chemotherapy , 1978, Cancer.
[10] Jane C. Wright,et al. SUMMARY OF RESULTS WITH TRIETHYLENE THIOPHOSPHORAMIDE , 1958, Annals of the New York Academy of Sciences.
[11] T. Winship,et al. Palliation of ovarian carcinoma with phosphoramide drugs. , 1956, Surgery, gynecology & obstetrics.
[12] D. Karnofsky,et al. Clinical studies on triethylenephosphoramide and diethylenephosphoramide, compounds with nitrogen‐mustard‐like activity , 1953 .
[13] J. Strain,et al. Patient noncompliance with self‐administered chemotherapy , 1990, Cancer.
[14] C. Redmond,et al. Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience. , 1986, NCI monographs : a publication of the National Cancer Institute.
[15] A. Miller,et al. Reporting results of cancer treatment , 1981, Cancer.